Postbiotic HM-6 Paradens Reduces Caries Pathogens in Paediatric Supplement Sector
A recent Polish pilot study indicates a novel non-viable Lactobacillus salivarius postbiotic can significantly reduce pathogenic bacteria linked to early childhood caries, presenting a new ingredient opportunity.
AI-assisted coverage: produced by SF News' automated newsroom from the cited sources and checked by automated attribution gates. Editorial responsibility: Lee Smith, Group CEO. How we work →
Warsaw, Poland — 02 April 2026
A randomised pilot study conducted in Poland has demonstrated that a chewable supplement containing a non-viable Lactobacillus salivarius strain, specifically HM-6 Paradens, can effectively reduce bacterial strains associated with early childhood tooth decay. The study involved children aged 3 to 6, a demographic segment frequently targeted by the oral health supplement market, and points towards a commercially viable preventative strategy.
Over a two-week period, children who received the postbiotic supplement exhibited decreased levels of harmful oral bacteria, including Lactobacillus spp. and Streptococcus mutans. Concurrently, an increase in beneficial Streptococcus spp. was observed within the oral microbiome of the active group. Notably, even the control group, which received parental oral hygiene guidance alone, showed some improvements in dental health parameters, underscoring the foundational role of regular hygiene.
Furthermore, both the group receiving the postbiotic and the control group experienced reductions in pathogenic yeast, which are also implicated in tooth decay. This finding suggests a broader antimicrobial effect or an enhancement of baseline oral hygiene practices across the participant cohort. The pilot study, while small, provides compelling preliminary data for this specific postbiotic's efficacy in modulating the paediatric oral microbiome.
What this means for United Kingdom
UK supplement manufacturers and brand owners should immediately evaluate HM-6 Paradens for inclusion in paediatric oral health formulations. This postbiotic offers a scientifically backed differentiator in a competitive market, potentially unlocking new product claims related to caries prevention. Procurement leads must assess supply chain availability and MOQ for HM-6 Paradens. Regulatory teams face a critical 18-24 month window for dossier preparation to comply with UK novel food regulations, ensuring market entry for products containing this ingredient. Early movers could capture significant market share in the £50M+ UK children's dental health supplement sector, leveraging health-conscious parental demand for evidence-based preventative solutions.
The study's findings encourage the integration of supervised oral hygiene practices with targeted postbiotic supplementation. Further research is cited as necessary to fully elucidate the precise mechanisms of action and to validate these pilot results in larger, more diverse populations. This will be critical for securing robust EFSA or FSA-approved health claims required for widespread market adoption and consumer trust.
For more on UK formulation and manufacturing best practice, learn more at Supplement Factory.